RecruitingNCT04696081

Atrial Fibrillation in Active Cancer Patients

Multicenter International Prospective Registry to Identify Major Cardiovascular Events Associated With the Occurrence of Atrial Fibrillation in Active Cancer Patients

Sponsor

University Hospital, Caen

Enrollment

1,000 participants

Start Date

Sep 1, 2021

Study Type

OBSERVATIONAL

Conditions

Cancer Atrial Fibrillation Cardiovascular Complication Drug Toxicity

Summary

Atrial fibrillation is a common complication of both cancer and anticancer drugs but the consequences of such events remain poorly known and are not adressed in both phase III oncological trials and cardiological guidelines. The objective of this study is to create a prospective multicenter international registry of adult patients with an active cancer and experiencing atrial fibrillation to study major cardiovascular events occurrence during a 1 year follow-up.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at how atrial fibrillation (an irregular heartbeat) affects people who currently have cancer. Researchers want to better understand how to manage this heart condition in cancer patients. **You may be eligible if...** - You are an adult (18+) - You have been diagnosed with cancer in the past 6 months, or have advanced/metastatic cancer receiving active treatment - You have had at least one episode of atrial fibrillation after your cancer diagnosis - Your heart was in normal rhythm at the time of your cancer diagnosis - You are an outpatient or currently hospitalized **You may NOT be eligible if...** - You are in palliative (end-of-life) care with death expected within a month - You had long-standing or permanent atrial fibrillation before your cancer diagnosis - Your cancer is a skin cancer (basal-cell or squamous-cell), primary brain tumor, brain metastases, or acute leukemia Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERoccurence of atrial fibrillation

all adult patients with an active cancer and experiencing atrial fibrillation will be consecutively include. Active cancers will be defined according Agnelli et al. (NEJM 2020; 382:1599-1607).